Publikationen, an denen er mitarbeitet Amor Rayco Cáceres Pérez (11)

2024

  1. Quality assessment of oral antimalarial and antiretroviral medicines used by public health systems in Sahel countries

    PLoS ONE, Vol. 19, Núm. 5 May

2023

  1. A pharmaceutical monitoring system to assess the quality of antituberculosis drug products used in Mauritania

    PLoS ONE, Vol. 18, Núm. 3 March

2022

  1. Development and Optimization of a New UPLC-UV/MS Method through DoE and MLR for Detecting Substandard Drug Products to Treat Tuberculosis

    Molecules, Vol. 27, Núm. 20

2021

  1. Diseño y desarrollo de un sistema automatizado para el control global de la impresión 3D de medicamentos pediátricos

    Congreso de la sociedad española de farmacia industrial y galénica (15º.2021.Sevilla)

  2. Diseño y desarrollo de un sistema automatizado para el control global de la impresión 3D de medicamentos pediátricos

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 18-20

  3. Individualized orodispersible pediatric dosage forms obtained by molding and semi-solid extrusion by 3D printing: A comparative study for hydrochlorothiazide

    Journal of Drug Delivery Science and Technology, Vol. 66

  4. Monitoring system for substandard detection of antituberculosis drugs used in the Mauritanian National Health System

    XV Congreso de la Sociedad Española de Farmacia Industrial y Galénica

  5. Monitoring system for substandard detection of antituberculosis drugs used in the Mauritanian National Health System

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 90-92

  6. Pharmaceutical equivalence and stability study of levofloxacin tablets commercialized in Europe and Africa

    XV Congreso de la Sociedad Española de Farmacia Industrial y Galénica

  7. Pharmaceutical equivalence and stability study of levofloxacin tablets commercialized in Europe and Africa

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 33-35

2020

  1. Stability study of isoniazid and rifampicin oral solutions using hydroxypropyl-Β-cyclodextrin to treat tuberculosis in paediatrics

    Pharmaceutics, Vol. 12, Núm. 2